Search Results

Dabigatran: A new orally available anticoagulant for prevention of strokes and thrombosis in patients with atrial fibrillation.

• Authors : Talati, Ripple (AUTHOR); White, C. Michael (AUTHOR)

Subjects: CEREBROVASCULAR disease prevention; THROMBOSIS prevention; ANTICOAGULANTS

• Source: Formulary. Feb2011, Vol. 46 Issue 2, p44-53. 6p. 1 Chart.

Record details

Effects of Aspirin on Growth Factor Release From Freshly Isolated Leukocyte-Rich Platelet-Rich Plasma in Healthy Men: A Prospective Fixed-Sequence Controlled Laboratory Study.

• Authors : Jayaram, Prathap; Yeh, Peter; Patel, Shiv J.

Subjects: ANALYSIS of variance; ARACHIDONIC acid; ASPIRIN

• Source: American Journal of Sports Medicine. Apr2019, Vol. 47 Issue 5, p1223-1229. 7p.

Record details

research highlights.

• Authors : Hopkin, Michael

Subjects: RESEARCH; PLANKTON; AQUATIC biology

• Source: Nature. 7/15/2004, Vol. 430 Issue 6997, p307-307. 1p.

Record details

Outcomes of Geriatric Trauma Patients on Preinjury Anticoagulation: A Multicenter Study.

• Authors : ANG, DARWIN; KUREK, STAN; MCKENNEY, MARK

Subjects: ANTICOAGULANTS; TRAUMA centers; TRAUMATIC shock (Pathology)FLORIDA

• Source: American Surgeon. Jun2017, Vol. 83 Issue 6, p527-535. 9p.

Record details

Plasma triacylglycerol and coagulation factor concentrations predict the anticoagulant effect of dietary fish oil in overweight subjects.

• Authors : Vanschoonbeek, Kristof; Feijge, Marion A. H.; Saris, Wim H. M.

Subjects: FISH oils; BLOOD coagulation factors; PROTHROMBIN

• Source: Journal of Nutrition. Jan2007, Vol. 137 Issue 1, p7-13. 7p. 4 Charts, 2 Graphs.

Record details

Misadministration of topical bovine thrombin.

• Authors : Gershon, S K (AUTHOR); Chang, A C (AUTHOR); Purvis, W V (AUTHOR)

Subjects: DISEASE complications; DRUG labeling; DRUG side effects

• Source: JAMA: Journal of the American Medical Association. 11/24/99, Vol. 282 Issue 20, p1919-1919. 1p.

Record details

In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.

• Authors : Kumar, Deepak; Moore, Robert M.; Mercer, Brian M.

Subjects: PREMATURE labor prevention; FETAL membranes; HYDROXYPROGESTERONE

• Source: American Journal of Obstetrics & Gynecology. Dec2017, Vol. 217 Issue 6, p695.e1-695.e14. 1p.

Record details

Clinical studies review findings on triple-antiplatelet therapy after PCI, investigational thrombin receptor antagonist.

• Authors : Kuznar, Wayne (AUTHOR)

Subjects: THROMBOSIS prevention; WARFARIN; DRUG therapyILLINOIS

• Source: Formulary. May2012, Vol. 47 Issue 5, p184-196. 9p. 1 Color Photograph, 2 Charts, 1 Graph.

Record details

Dabigatran may be a cost-effective alternative to warfarin for stroke prevention in atrial fibrillation.

Subjects: CEREBROVASCULAR disease prevention; DRUG therapy; WARFARIN

• Source: Formulary. Feb2011, Vol. 46 Issue 2, p39-39. 1/2p.

Record details

Progesterone inhibits in vitro fetal membrane weakening.

• Authors : Kumar, Deepak; Springel, Edward; Moore, Robert M.

Subjects: PROGESTERONE; FETAL membranes; INFLAMMATION

• Source: American Journal of Obstetrics & Gynecology. Oct2015, Vol. 213 Issue 4, p520.e1-520.e9. 1p.

Record details